Send to

Choose Destination
Gan To Kagaku Ryoho. 1986 Aug;13(8):2532-7.

[Clinical study of PSK as an adjuvant immunochemotherapeutic agent against gastric cancer].

[Article in Japanese]


The effects of PSK in combination with Mitomycin C, Adriamycin and Tegafur were studied in 168 patients who underwent gastrectomy for gastric cancer. The study group receiving PSK showed improved survival and there was a significant difference in the estimated survival. An improved survival rate was also shown at stages III and IV, in the group given an FAM regimen and in the group with well differentiated adenocarcinoma.

[Indexed for MEDLINE]

Supplemental Content

Loading ...
Support Center